X

Health Care

Vertex Pharmaceuticals Incorporated (VRTX) Q3 2022 Earnings Call Transcript

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q3 2022 earnings call dated Oct. 27, 2022 Corporate Participants: Susie Lisa -- Senior Vice President, Investor…

BioMarin Pharmaceutical Inc. (BMRN) Q3 2022 Earnings Call Transcript

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Traci McCarty -- Vice President of Investor…

Merck & Co Inc (MRK) Q3 2022 Earnings Call Transcript

Merck & Co Inc (NYSE:MRK) Q3 2022 Earnings Call dated Oct. 27, 2022. Corporate Participants: Peter Dannenbaum -- Vice President of Investor…

ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while…

Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings

Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when…

IQVIA Holdings Inc. (IQV) Q3 2022 Earnings Call Transcript

IQVIA Holdings Inc. (NYSE: IQV) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Nick Childs -- Senior Vice President, Investor…

Thermo Fisher Scientific Inc. (TMO) Q4 2022 Earnings Call Transcript

Thermo Fisher Scientific Inc. (NYSE: TMO) Q4 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Rafael Tejada -- Vice President, Investor…

Boston Scientific Corp. (BSX) Q3 2022 Earnings Call Transcript

Boston Scientific Corp. (NYSE: BSX) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations…

BIIB Stock: Is Biogen an investment worth trying now?

Biogen Inc. (NASDAQ: BIIB) has been going through a rough patch for some time as the company's popular products faced…

Bristol Myers Squibb (BMY) Earnings: 3Q22 Key Numbers

Bristol Myers Squibb (NYSE: BMY) reported revenues of $11.2 billion for the third quarter of 2022, down 3% from the…